KB-3061 Is a Potent Activator of Wild Type KCNQ Channels and Restores Current to KCNQ2 Encephalopathy Variants In Vitro

Dec 9 | Kv7, Presentations

Discovery and characterization of KB3061: A potent Kv7.2/7.3 ion channel activator for the treatment of KCNQ2 epileptic encephalopathy

Dec 9 | Kv7, Presentations

Kv7.2/7.3 Activators as Precision Medicines for the Treatment of KCNQ2-EE

Sep 17 | Kv7, Presentations

The re-emergence of Kv7 drug discovery

Sep 13 | Kv7, Presentations

Developing Dexpramipexole for the Treatment of Eosinophilic Disorders

Jul 9 | Dexpramipexole, Presentations

Dexpramipexole Responsiveness is Increased in Eosinophilic Subjects

Jul 9 | Dexpramipexole, Presentations

Targeting Kv7.2/7.3 Activators for the Treatment of KCNQ2-NEE

May 24 | Kv7, Presentations